Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparison of a Treatment Strategy Combining CCI-779 Plus DTIC Versus DTIC Monotreatment in Human Melanoma in SCID Mice  Christiane Thallinger, Johannes.

Published byLeo Slettebakk Modified over 5 years ago

Similar presentations

Presentation on theme: "Comparison of a Treatment Strategy Combining CCI-779 Plus DTIC Versus DTIC Monotreatment in Human Melanoma in SCID Mice  Christiane Thallinger, Johannes."— Presentation transcript:

1 Comparison of a Treatment Strategy Combining CCI-779 Plus DTIC Versus DTIC Monotreatment in Human Melanoma in SCID Mice  Christiane Thallinger, Johannes Werzowa, Wolfgang Poeppl, Florian M. Kovar, Barbara Pratscher, Peter Valent, Peter Quehenberger, Christian Joukhadar  Journal of Investigative Dermatology  Volume 127, Issue 10, Pages (October 2007) DOI: /sj.jid Copyright © 2007 The Society for Investigative Dermatology, Inc Terms and Conditions

2 Figure 1 Expression of mTOR, Akt, PTEN, and S6K1 in human melanoma cells. (a) Relevant key parts of the mTOR/Akt pathway were evaluated by Western blot (10% polyacrylamide gel). The target structure of CCI-779, namely p-mTOR, was expressed in all three melanoma cell lines. PTEN, a tumor suppressor, was most weakly expressed in Mel-JUSO and strongest in 607B human melanoma cell lines. (b) Treatment of human melanoma cells with CCI-779 increased the expression of p-Akt, when compared to untreated controls in all three melanoma cell lines evaluated. In contrast, protein expression of p-S6K1 decreased when treated with CCI-779. Each lane was loaded with 10μg protein. Representative blots of different gels are shown. (c) Quantification of Western blot bands by densitometry. Data are presented as a percentage of controls (actin). Journal of Investigative Dermatology  , DOI: ( /sj.jid ) Copyright © 2007 The Society for Investigative Dermatology, Inc Terms and Conditions

3 Figure 2 Effect of CCI-779 treatment on melanoma growth in SCID mice. Depending on the cell lines used, the overall observation period varied from 23 to 34 days. SCID mice with 518A2, Mel-JUSO, or 607B melanomas received a 14-day treatment (day 1–14) with CCI-779 (1.5mg/kg intraperitoneally) or solvent control (6–10 animals per group). In addition, animals received 80mg/kg of DTIC intraperitoneally on treatment days 4–8. At the end of the experiment, mice were killed and tumors were resected and weighed (right panel). Tumor weight is provided in grams. During the course of the experiment, tumor size was assessed by caliper measurements (left panel) twice weekly and is shown in mm3 (mean±SD; =statistically significant, P<0.05; n.s.=not significant, P>0.05). Journal of Investigative Dermatology  , DOI: ( /sj.jid ) Copyright © 2007 The Society for Investigative Dermatology, Inc Terms and Conditions

4 Figure 3 Treatment with CCI-779 plus DTIC facilitates apoptosis in vivo. Melanoma xenografts treated with either the combination of CCI-779 plus DTIC or DTIC solely were analyzed by TUNEL assay for apoptotic cell death. TUNEL-positive cells (green) increased in tumors treated with CCI-779 plus DTIC in Mel-JUSO and 607B xenografts compared to DTIC monotreatment. (Bar=0.1mm.) Representative photographs of tumor sections are shown. Journal of Investigative Dermatology  , DOI: ( /sj.jid ) Copyright © 2007 The Society for Investigative Dermatology, Inc Terms and Conditions

5 Figure 4 Expression of p70 S6K before and after treatment with CCI-779 in vivo. Melanoma xenografts treated with either CCI-779 or solvent control were analyzed by immunohistochemistry for cytoplasmic and nuclear p70 S6K protein expression. Cytoplasmic p70 S6K expression impressively decreased after CCI-779 treatment, whereas the nuclear expression pattern remained nearly unaffected. (Bar=0.1mm upper panel; bar=0.015mm lower panel.) Representative photographs of tumor sections are shown. Journal of Investigative Dermatology  , DOI: ( /sj.jid ) Copyright © 2007 The Society for Investigative Dermatology, Inc Terms and Conditions

6 Figure 5 Expression of mTOR, Akt, PTEN, and S6K1 in human melanomas grown in SCID mice. p-mTOR and PTEN protein expression of human melanomas grown in SCID mice were not influenced by the treatment with CCI-779. In contrast, treatment of human melanomas with CCI-779 increased the expression of p-Akt when compared to untreated controls and induced additionally a slight decrease of p-S6K1 protein expression (15μg protein were loaded per lane). Representative blots of different gels are shown. Journal of Investigative Dermatology  , DOI: ( /sj.jid ) Copyright © 2007 The Society for Investigative Dermatology, Inc Terms and Conditions

Download ppt "Comparison of a Treatment Strategy Combining CCI-779 Plus DTIC Versus DTIC Monotreatment in Human Melanoma in SCID Mice  Christiane Thallinger, Johannes."

Similar presentations

Figure 1. Herbacetin binds to AKT1/2 and suppresses each respective kinase activity. The effect of herbacetin on (A) PI3K/AKT and (B) MAPK signaling pathway.

Figure 1. Herbacetin binds to AKT1/2 and suppresses each respective kinase activity. The effect of herbacetin on (A) PI3K/AKT and (B) MAPK signaling pathway.
Jane L. Armstrong, David S. Hill, Christopher S

Jane L. Armstrong, David S. Hill, Christopher S
A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma  Xuan Qu, Liangliang Shen,

A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma  Xuan Qu, Liangliang Shen,
Vemurafenib Induces Senescence Features in Melanoma Cells

Vemurafenib Induces Senescence Features in Melanoma Cells
Volume 19, Issue 7, Pages (July 2017)

Volume 19, Issue 7, Pages (July 2017)
Keloid Fibroblasts Resist Ceramide-Induced Apoptosis by Overexpression of Insulin- Like Growth Factor I Receptor  Hiroshi Ishihara, Hiroshi Yoshimoto,

Keloid Fibroblasts Resist Ceramide-Induced Apoptosis by Overexpression of Insulin- Like Growth Factor I Receptor  Hiroshi Ishihara, Hiroshi Yoshimoto,
Volume 191, Issue 1, Pages (January 2014)

Volume 191, Issue 1, Pages (January 2014)
Cyclooxygenase-2 Overexpression in Human Basal Cell Carcinoma Cell Line Increases Antiapoptosis, Angiogenesis, and Tumorigenesis  Jeng-Wei Tjiu, Yi-Hua.

Cyclooxygenase-2 Overexpression in Human Basal Cell Carcinoma Cell Line Increases Antiapoptosis, Angiogenesis, and Tumorigenesis  Jeng-Wei Tjiu, Yi-Hua.
Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in Skin  Xuesong Wu,

Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in Skin  Xuesong Wu,
Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells  Edgar Selzer, Emilio Pimentel, Volker Wacheck, Werner Schlegel,

Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells  Edgar Selzer, Emilio Pimentel, Volker Wacheck, Werner Schlegel,
Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.

Type I IL-1 Receptor Mediates IL-1 and Intracellular IL-1 Receptor Antagonist Effects in Skin Inflammation  Gaby Palmer, Dominique Talabot-Ayer, Gürkan.
Inhibition of UVB-Induced Skin Tumor Development by Drinking Green Tea Polyphenols Is Mediated Through DNA Repair and Subsequent Inhibition of Inflammation 

Inhibition of UVB-Induced Skin Tumor Development by Drinking Green Tea Polyphenols Is Mediated Through DNA Repair and Subsequent Inhibition of Inflammation 
Tumor Necrosis Factor α Increases and α-Melanocyte-Stimulating Hormone Reduces Uveal Melanoma Invasion Through Fibronectin  Irene Cantón, Paula C. Eves,

Tumor Necrosis Factor α Increases and α-Melanocyte-Stimulating Hormone Reduces Uveal Melanoma Invasion Through Fibronectin  Irene Cantón, Paula C. Eves,
Efficient TRAIL-R1/DR4-Mediated Apoptosis in Melanoma Cells by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)  Bahtier M. Kurbanov, Christoph.

Efficient TRAIL-R1/DR4-Mediated Apoptosis in Melanoma Cells by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)  Bahtier M. Kurbanov, Christoph.
Volume 8, Issue 6, Pages (December 2005)

Volume 8, Issue 6, Pages (December 2005)
Volume 62, Issue 2, Pages (August 2002)

Volume 62, Issue 2, Pages (August 2002)
Plakoglobin Deficiency Protects Keratinocytes from Apoptosis

Plakoglobin Deficiency Protects Keratinocytes from Apoptosis
Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells  Nabanita Mukherjee, Steven.

Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells  Nabanita Mukherjee, Steven.
Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non–small cell lung cancer in vitro and in vivo 

Inhibition of phosphatidylinositol 3-kinase/Akt and histone deacetylase activity induces apoptosis in non–small cell lung cancer in vitro and in vivo 
Molecular Therapy - Nucleic Acids

Molecular Therapy - Nucleic Acids

Similar presentations

Ads by Google